InterVest Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
24
- Investments
-
192
- Portfolio
-
129
- Exits
-
38
InterVest General Information
Company Description
Founded in 1999, InterVest is a venture capital firm based in Seoul, South Korea. The firm seeks to invest in seed-stage, early-stage, and later-stage companies operating in artificial intelligence, fintech, metaverse, energy & environmental, social and governance, semiconductor, consumer & platform, mobility, smart society, space tech, decentralized finance& centralized finance, non-fungible token, and biotech & healthcare sectors based in Singapore, Republic of Korea, Vietnam, Indonesia, Malaysia, India, and the United States.
Business Details
Website
intervest.co.krYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Suite 1701 Trade Tower, 511, Yeongdong-daero
- Gangnam-gu
- Seoul, 06164
- South Korea
InterVest Investments (192)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Genkore | 03-Jan-2025 | Later Stage VC | Biotechnology | Generating Revenue | ||
| Neutune | 04-Dec-2024 | Business/Productivity Software | Generating Revenue | |||
| Brandazine | 06-Nov-2024 | Media and Information Services (B2B) | Generating Revenue | |||
| Primemas | 01-Nov-2024 | Application Specific Semiconductors | Generating Revenue | |||
| liner | 11-Oct-2024 | Internet Software | Generating Revenue | |||
| VoyagerX | 10-Oct-2024 | Software Development Applications | Generating Revenue | |||
| Holiday Robotics | 27-Aug-2024 | Other Hardware | Startup | |||
| Neptune Medical | 15-Aug-2024 | Diagnostic Equipment | Generating Revenue | |||
| Aimedbio | 31-Jul-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| ABL Bio | 11-Jul-2024 | PIPE | Drug Discovery | Generating Revenue/Not Profitable |
InterVest Exits (38)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Craver. | 03-Dec-2024 | Buyout/LBO | |
| Tomocube | 07-Nov-2024 | ||
| Clobot | 28-Oct-2024 | ||
| Publy | 19-Sep-2024 | ||
| Innospace | 02-Jul-2024 | ||
| Dekoruma | 21-Jun-2024 | ||
| Gridwiz | 14-Jun-2024 | ||
| D&D Pharmatech | 02-May-2024 | ||
| YBiologics | 05-Dec-2023 | IPO | |
| Curocell | 09-Nov-2023 | IPO |
InterVest Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
InterVest Co-Investors (362)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Korea Development Bank | 15 |
|
|
||
| Company K Partners |
|
|
|||
| DSC Investment |
|
|
|||
| KB Investment |
|
|
|||
| Atinum Investment |
|
|
InterVest FAQs
-
What is InterVest?
Founded in 1999, InterVest is a venture capital firm based in Seoul, South Korea.
-
When was InterVest founded?
InterVest was founded in 1999.
-
Where is InterVest headquartered?
InterVest is headquartered in Seoul, South Korea.
-
What is InterVest's total asset value?
InterVest has around in total assets under management.
-
How many investments has InterVest made?
InterVest has made 192 investments.
-
What has InterVest invested in?
InterVest has made numerous investments in companies like Genkore, Neutune, and Brandazine within the Biotechnology, Business/Productivity Software, and Media and Information Services (B2B) industries.
-
What has InterVest invested in recently?
InterVest's latest investment was on 03-Jan-2025 in Genkore, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
